Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study (vol 27, pg 563, 2022)

被引:0
|
作者
Kato, Renpei [1 ]
Naito, Sei [2 ]
Numakura, Kazuyuki [3 ]
Hatakeyama, Shingo [4 ]
Koguchi, Tomoyuki [5 ]
Kojima, Takahiro [6 ]
Kawasaki, Yoshihide [7 ]
Kandori, Shuya [6 ]
Kawamura, Sadafumi [8 ]
Arai, Yoichi [8 ]
Ito, Akihiro [7 ]
Nishiyama, Hiroyuki [6 ]
Kojima, Yoshiyuki [5 ]
Ohyama, Chikara [4 ]
Habuchi, Tomonori [3 ]
Tsuchiya, Norihiko [2 ]
Obara, Wataru [1 ]
机构
[1] Iwate Med Univ, Dept Urol, Sch Med, 2-1-1 Idaidori, Yahaba, Shiwa 0283695, Japan
[2] Yamagata Univ, Dept Urol, 2-2-2 Iida Nishi, Sch Med, Yamagata 9909585, Japan
[3] Akita Univ, Dept Urol, Sch Med, 1-1-1 Hondo, Akita 0108543, Japan
[4] Hirosaki Univ Grad Med, Dept Urol & Adv Blood Purificat Therapy, 5 Zaifuchou, Hirosaki 0368562, Japan
[5] Fukushima Med Univ, Dept Urol, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan
[6] Univ Tsukuba, Dept Urol, Grad Sch Med, 1-1-1 Tennodai, Tsukuba 3058575, Japan
[7] Tohoku Univ, Dept Urol, Sch Med, 2-1 Seiryo Machi,Aoba Ku, Sendai 9808575, Japan
[8] Miyagi Canc Ctr, Dept Urol, 47-1 Natori, Aijima, Natori 9811293, Japan
关键词
D O I
10.1007/s10147-023-02331-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:726 / 727
页数:2
相关论文
共 50 条
  • [1] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
    Renpei Kato
    Sei Naito
    Kazuyuki Numakura
    Shingo Hatakeyama
    Tomoyuki Koguchi
    Takahiro Kojima
    Yoshihide Kawasaki
    Shuya Kandori
    Sadafumi Kawamura
    Yoichi Arai
    Akihiro Ito
    Hiroyuki Nishiyama
    Yoshiyuki Kojima
    Chikara Ohyama
    Tomonori Habuchi
    Norihiko Tsuchiya
    Wataru Obara
    International Journal of Clinical Oncology, 2022, 27 : 563 - 573
  • [2] Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study
    Kato, Renpei
    Naito, Sei
    Numakura, Kazuyuki
    Hatakeyama, Shingo
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Shuya
    Kawamura, Sadafumi
    Arai, Yoichi
    Ito, Akihiro
    Nishiyama, Hiroyuki
    Kojima, Yoshiyuki
    Ohyama, Chikara
    Habuchi, Tomonori
    Tsuchiya, Norihiko
    Obara, Wataru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (03) : 563 - 573
  • [3] Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study
    Renpei Kato
    Sei Naito
    Kazuyuki Numakura
    Shingo Hatakeyama
    Tomoyuki Koguchi
    Takahiro Kojima
    Yoshihide Kawasaki
    Shuya Kandori
    Sadafumi Kawamura
    Yoichi Arai
    Akihiro Ito
    Hiroyuki Nishiyama
    Yoshiyuki Kojima
    Chikara Ohyama
    Tomonori Habuchi
    Norihiko Tsuchiya
    Wataru Obara
    International Journal of Clinical Oncology, 2023, 28 : 726 - 727
  • [4] The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    You, Dalsan
    Jeong, In Gab
    Ahn, Jin-Hee
    Lee, Dae Ho
    Lee, Jae-Lyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2011, 185 (01): : 54 - 59
  • [5] SURVIVAL FOLLOWING UPFRONT CYTOREDUCTIVE NEPHRECTOMY VERSUS TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA
    Bhindi, Bimal
    Habermann, Elizabeth
    Mason, Ross
    Costello, Brian
    Pagliaro, Lance
    Thompson, R. Houston
    Leibovich, Bradley
    Boorjian, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E486 - E486
  • [6] VALUE OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA DURING THE TARGETED THERAPY ERA
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Jung, Han
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2010, 183 (04): : E641 - E641
  • [7] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [8] Cytoreductive nephrectomy for metastatic renal cell carcinoma: Is it still imperative in the era of targeted therapy?
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Figlin, Robert A.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 693S - 696S
  • [9] Survival following upfront cytoreductive nephrectomy versus targeted therapy for metastatic renal cell carcinoma.
    Bhindi, Bimal
    Habermann, Elizabeth Butzer
    Mason, Ross
    Costello, Brian Addis
    Pagliaro, Lance C.
    Thompson, Robert Houston
    Leibovich, Bradley C.
    Boorjian, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Rodriguez Faba, Oscar
    Brookman-May, Sabine D.
    Linares, Estefania
    Breda, Alberto
    Pisano, Francesca
    Daniel Subiela, Jose
    Sanguedolce, Francesco
    Brausi, Maurizio
    Palou, Joan
    WORLD JOURNAL OF UROLOGY, 2017, 35 (12) : 1807 - 1816